• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Am J Infect Control Absence of Nosocomial Transmission of Coronavirus Disease 2019 (COVID-19) Due to SARS-CoV-2 in the Pre-Pandemic Phase in Hong Kon

tetano

Editor, Senior Moderator
Am J Infect Control


. 2020 May 24;S0196-6553(20)30280-7.
doi: 10.1016/j.ajic.2020.05.018. Online ahead of print.
Absence of Nosocomial Transmission of Coronavirus Disease 2019 (COVID-19) Due to SARS-CoV-2 in the Pre-Pandemic Phase in Hong Kong


Vincent C C Cheng[SUP] 1 [/SUP], Shuk-Ching Wong[SUP] 2 [/SUP], Vivien W M Chuang[SUP] 3 [/SUP], Simon Y C So[SUP] 4 [/SUP], Jonathan H K Chen[SUP] 4 [/SUP], Siddharth Sridhar[SUP] 5 [/SUP], Kelvin K W To[SUP] 5 [/SUP], Jasper F W Chan[SUP] 5 [/SUP], Ivan F N ****[SUP] 6 [/SUP], Pak-Leung Ho[SUP] 5 [/SUP], Kwok-Yung Yuen[SUP] 7 [/SUP]



Affiliations

Abstract

Background: To describe the infection control strategy to achieve zero nosocomial transmission of symptomatic coronavirus disease (COVID-19) due to SARS-CoV-2 during the pre-pandemic phase (the first 72 days after announcement of pneumonia cases in Wuhan) in Hong Kong.
Methods: Administrative support with the aim of zero nosocomial transmission by reducing elective clinical services, decanting wards, mobilizing isolation facilities, providing adequate personal protective equipment, coordinating laboratory network for rapid molecular diagnosis under 4-tier active surveillance for hospitalized- and out-patients, and organizing staff forum and training was implemented under the framework of preparedness plan in Hospital Authority. The trend of SARS-CoV-2 in the first 72 days was compared with that of SARS-CoV 2003.
Results: Up to day 72 of the epidemic, 130 (0.40%) of 32,443 patients being screened confirmed to have SARS-CoV-2 by RT-PCR. Compared with SARS outbreak in 2003, the SARS-CoV-2 case load constituted 8.9% (130 SARS-CoV-2/1458 SARS-CoV) of SARS-CoV infected cases at day 72 of the outbreak. The incidences of nosocomial acquisition of SARS-CoV per-1,000-SARS-patient-day and per-100-SARS-patient-admission were 7.9 and 16.9 respectively, which were significantly higher than the corresponding incidences of SARS-CoV-2 (zero infection, p<0.001).
Conclusion: Administrative support to infection control could minimize the risk of nosocomial transmission of SARS-CoV-2.

Keywords: Absence; COVID-19; Hong Kong; SARS-CoV-2; coronavirus disease 2019; nosocomial transmission.
 
Back
Top Bottom